October 22, 2017 12:33 PM ET


Company Overview of Javelin Pharmaceuticals, Inc.

Company Overview

Javelin Pharmaceuticals, Inc. researches, develops, manufactures, and commercializes pharmaceuticals for the relief of moderate to severe pain primarily in the United States and Europe. Its product line primarily includes Dyloject, an injectable diclofenac; Ereska, an intranasal ketamine; and Rylomine, an intranasal morphine that completed the phase III development stage. The company offers its products for treating various pain disorders, such as acute and episodic moderate-to-severe pain associated with breakthrough cancer pain; post-operative pain; and post-trauma pain, such as orthopedic injury pain, procedural pain, and burn pain. It has license agreements with Shimoda Biotech, Ltd. to ...

125 CambridgePark Drive

Cambridge, MA 02140

United States

Founded in 1998

21 Employees





Key Executives for Javelin Pharmaceuticals, Inc.

President, Chief Medical Officer, and Vice Chairman
Age: 68
Compensation as of Fiscal Year 2017.

Similar Private Companies By Industry

Company Name Region
1st Order Pharmaceuticals, Inc. United States
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Tax Management Inc United States
Bertelsmann AG Europe

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Javelin Pharmaceuticals, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.